Partnering with Inhibikase

Inhibikase actively seeks to collaborate with pharmaceutical and biotechnology partners based on a shared, strategic focus to create innovative new kinase inhibitor drugs that treat safely and effectively in the brain.

For more information, please contact:
Milton H. Werner, Ph.D.
President & CEO
917 494 0831 (m)

Back to Top